ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹231 Cr | ₹8459 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.35 | 1.82 |
| Manager | Rohan Korde | Sailesh Raj Bhan |
| ISIN Code | INF00XX01BL5 | INF204K01968 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -1.49% | -0.68% |
| 6 Month | -0.87% | 1.24% |
| 1 Year | -6.79% | -0.43% |
| 3 Year | 18.86% | 21.46% |
| 5 Year | - | 15.44% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -3.88% | -1.66% |
| 1 Year | -3.89% | 2.66% |
| 3 Year | 13.18% | 15.82% |
| 5 Year | - | 16.04% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 18.94% | 16.62% |
| 3 Year | 20.21% | 20.93% |
| 5 Year | - | 20.36% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 15.68% | 14.36% |
| Sharp | 0.75% | 0.98% |
| Beta | 0.95% | 0.87% |
| Alpha | -3.33% | 1.45% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Rohan Korde | Sailesh Raj Bhan |
| Total AUM | ₹4626 Cr | ₹96086 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 4.69 | 1.34 |
| Large Cap | 31.32 | 32.6 |
| Mid Cap | 36.99 | 35.32 |
| Small Cap | 27.01 | 30.74 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 2.72 | 0.55 |
| Healthcare | 92.93 | 99.45 |
| Industrials | 0.97 | - |
| Financial Services | 1.26 | - |
| Basic Materials | 2.12 | - |
Top Comparisons
Mahindra Manulife Small Cap Fund - Regular Plan - Growth
3Y Returns26.37%
Tata Small Cap Fund Regular Growth
3Y Returns17.46%
NIPPON INDIA QUARTERLY INTERVAL FUND SERIES II IDCW PLAN REINVESTMENT
3Y Returns6.85%
NIPPON INDIA QUARTERLY INTERVAL FUND SERIES II IDCW PLAN REINVESTMENT
3Y Returns6.85%
DSP Multi Asset Allocation Fund - Regular (G)
3Y Returns0%
Edelweiss Multi Asset Allocation Fund - Reg (G)
3Y Returns0%
Motilal Oswal Large Cap Fund - Regular (G)
3Y Returns0%
DSP Large Cap Fund - Regular Plan - Growth
3Y Returns18.9%